ir.synageva.com
Synageva :: Investor Relations
Effective June 23, 2015 Synageva BioPharma Corp. is now part of Alexion Pharmaceuticals, Inc. You will be redirected in 10 seconds. Our Mission / Commitment. What is a Rare Disease? Section 16 Filings (3,4,5). Synageva BioPharma Corp. (NASDAQ: GEVA). Synageva is a biopharmaceutical company dedicated to discovering, developing and delivering medicines for patients with rare diseases and high unmet medical needs. We are passionate about our commitment to improving the lives of patients for generations ...
ir.syndax.com
Investors – Syndax
Annual Reports and Proxies. Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA. Day High: 7.40.
ir.synnex.com
Investor Relations | SYNNEX Corporation
Skip to main navigation. Technology Solutions Executive Team. New Age Electronics (U.S.). SYNNEX Completes Acquisition of Westcon-Comstor North America and Latin America Businesses. Annual Reports and Proxies. Mar 29, 2018. SYNNEX Corporation Reports First Quarter Fiscal 2018 Results. Mar 20, 2018. SYNNEX Corporation Launches Exclusive IT Reseller Community Focused on Technology Convergence. Sign up for email alerts. Mar 29, 2018 5:00 PM EDT. Q1 2018 SYNNEX Corporation Earnings Conference Call.
ir.syntapharma.com
Synta Pharmaceuticals Corp : Investors : Investor Overview
Trials by Tumor Type. Synta Pharmaceuticals is an innovative, agile biopharmaceutical company focused on research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients. . 160;- 0.01. Aug 07, 2015 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. Synta Reports Second Quarter 2015 Financial Results. Aug 06, 2015. Synta to Host Conference Call and Webcast of Second Quarter 2015 Financial Results on August 6, 2015.
ir.synthesisenergy.com
Investor Center | Synthesis Energy Systems, Inc.
Skip to main navigation. How Syngas is Used. Why Syngas is Important. Global Need and Resources. The Future of Gasification. The Real Cost of Energy. SGT: How It Works. How Syngas is Used. Why Syngas is Important. Global Need and Resources. The Future of Gasification. The Real Cost of Energy. SGT: How It Works. DRI for Steel Production. Clean Economic. Sustainable. Growth With Blue Skies. Synthesis Energy Systems, Inc. 30th Annual ROTH Conference 2018 Presentation. Mar 26, 2018. Mar 12, 2018. Mar 5, 2018.
ir.syntheticbiologics.com
Investor Relations :: Synthetic Biologics, Inc. (SYN)
Jan 5, 2017. Synthetic Biologics' SYN-004 (ribaxamase) Achieves Primary Endpoint in Phase 2b Trial for C. difficile Infection (CDI). Sep 30, 2016. Sign Up for Email Alerts Sign Up Today. Our experienced management team holds an extensive clinical and commercial track record. View Board of Directors. Synthetic Biologics, Inc. Corporate Stock Transfer, Inc. 3200 Cherry Creek Drive South. Denver, CO 80209.
ir.synu.edu.cn
沈阳师范大学机构知识库: Home
CALIS Institutional Repository (CALIS IR) is the academic research infrastructure of school. It's a central, open-access repository of research by members of the Peking University. Research Field : 古生物学、地层学，专长于中生代植物及早期被子植物研究。 Research Field : 从事现、当代文学和前沿文化、文学研究。 Research Field : 两栖爬行动物资源和保护生物学研究工作. New in CALIS IR. Institutional Repository Project Group, Powered by DSpace Feedback. Number of Online Users: 212 Total of Site Visit: 3297032.
ir.sypris.com
Sypris Solutions Inc. (SYPR) - Investor Information
Q2 2015 Sypris Solutions Inc. Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Sypris Solutions Inc. Earnings Conference Call. Tuesday, August 18, 2015 . 9:00 am ET . Click here for webcast. Sypris Solutions, Inc. Louisville, KY 40222. 160; 0.09. Data as of 08/17/15 4:00 pm ET. Minimum 20 minute delay. Sypris Solutions, Inc. to Announce Second Quarter Financial Results, Host Conference Call and Webcast on August 18. Sypris Reports First Quarter Results. Sypris Reports 2014 Results. Industrial Margin...
ir.syzygy.co.uk
www.syzygy.net
WELCOME AT SYZYGY AG! SYZYGY AG is an award-winning agency group for digital marketing, listed since the year 2000. Employing some 500 people, the Group provides creative, media and technology services. Offices are based in Bad Homburg, Berlin, Hamburg, Frankfurt, Munich, London, New York and Warsaw. SYZYGY`s client list includes renowned brands such as Avis, BMW, Chanel, Daimler, Discovery Channel, Jägermeister, Mazda, nvidia, o2, playstation and Telekom. In 2014, SYZYGY Group continued to grow dynamica...
ir.syzygy.net
SYZYGY Group - Agenturgruppe für digitales Marketing
HERZLICH WILLKOMMEN BEI DER SYZYGY AG! SYZYGY ist eine international tätige Agenturgruppe für digitales Marketing mit über 500 Mitarbeitern und Standorten in Bad Homburg, Berlin, Frankfurt, Hamburg, London, New York und Warschau. Seit 2000 ist SYZYGY im Prime Standard börsennotiert. Als Kreativ-, Media- und Technologiedienstleister betreut die Gruppe Großunternehmen und renommierte Marken wie AVIS, BMW, Chanel, Daimler, Discovery Channel, Jägermeister, KfW, Mazda, nvidia, o2, Playstation und die Telekom.
ir.szabist.edu.pk
Institutional Research Development
Bringing standardized quality to Academics. Welcome to SZABIST Quality Enhancement Cell. Welcome to SZABIST online Quality Enhancement Cell and Institutional Research department. We serve our institute by ensuring that quality education is delivered at SZABIST and it meets the guidelines set by the Higher Education Commission of Pakistan. Quality Enhancement Cell Achieves the Highest Ranking. SZABIST's QEC scored "93.90%" in their quantitative assessment for the period of July 2015-June 2016. Thi...
